Image

Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease

Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This is a medical record data collection study. The goal of this non-interventional and retrospective study is to describe the characteristics of the population currently being monitored for bronchial dilatation who have been treated with long-term NIV. This is a study based on data from medical records.

The assessment criteria will be :

  • Epidemiological characteristics of the population with bronchial dilatation on long-term NIV
  • Reasons for initiation of NIV
  • NIV adjustment methods

Description

Non-invasive ventilation is a treatment sometimes used for severe severe bronchial dilatation, but to date there are no studies its efficacy.

The expected results in this context are :

  • a description of the characteristics of patients with severe bronchial on non-invasive ventilation (NIV)
  • a better understanding, during NIV management, of the settings used, the tolerance and effectiveness of NIV in reducing exacerbations, hospital admissions and patient mortality.
  • move towards better patient management

Data will be extracted from patient medical records and the PMSI.

Eligibility

Inclusion Criteria:

  • Patients over 18 years
  • Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis, confirmed by computed tomography
  • Introduction of long-term NIV at a given point in the patient's care

Exclusion Criteria:

  • Patient's opposition to participating in this study
  • Cystic fibrosis
  • Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis resulting from focal endobronchial lesion, sarcoidosis or active allergic bronchopulmonary aspergillosis.

Study details
    Bronchial Dilatation Disease
    Bronchectasie

NCT06987461

Centre Hospitalier Intercommunal Creteil

3 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.